The emerging therapy of this peptide represents a exciting advance in the management of diabetes mellitus type 2. Different to existing medications, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide685523.mpeblog.com/76220906/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment